Request an Edit
Skip to main content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Utility Nav
CHOP.EDU
Careers
Ways to Give
Healthcare Professionals
International
Children's Hospital of Philadelphia
Menu
SEARCH
Main navigation
Find People
Our Research
Clinical Trials
About
Innovation
Faculty & Staff Resources
Make a Gift
HO
1 - 1 of
1
CHOP Researchers Develop First Drug Treatment Approved for Severe Bone Disease
Published on
Jan 31, 2022
in
Cornerstone Blog
Identified by CHOP researchers, palovarotene is the first drug approved (in Canada) for fibrodysplasia ossificans progressiva, a severe bone disease.